Maxaquin in the combined treatment of tuberculosis
Sokolova, G.B.; Mozhokina, G.N.; Kunichan, A.D.; Elistratova, N.A.; Perel'man, M.I.
Problemy Tuberkuleza 5: 35-39
2000
ISSN/ISBN: 0032-9533 PMID: 11077850 Document Number: 517861
In the context of experimental and clinical pharmacology, the paper provides evidence for that use of Maxaquine, a fluoroquinolone agent, is effective in the combined therapy of tuberculosis. Indications for its clinical use, dosage, and administration rates have been defined. Treatment regimens for patients isolating drug-sensitive and drug-resistant Mycobacteria tuberculosis in the presence or absence of contaminant nonspecific respiratory infections are presented. The duration of combined therapy has been defined depending on the pattern of a process and comorbidity.